Skip to content
The Cancer History Project
HOME
ABOUT
THE CANCER HISTORY PROJECT
THE CANCER LETTER
EDITORIAL BOARD
SPONSORS
CONTRIBUTORS
TCL ARCHIVES
LATEST ARTICLES
Search for:
Search
ARCHIVES
Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.
This article is from
The Cancer Letter
archive.
Vol. 28 No. 09 | March 1, 2002
Download PDF
Visit The Full Archive
Related Articles
TCL Archive
French Cancer Group Vow to Spend More On Cancer Research
January 12, 1996
TCL Archive
ACS Report Says Drop in Cancer Mortality Saved 898,000 Lives Over 17 Years
June 17, 2011
TCL Archive
MGMT Gene Can Determine Disease Aggressiveness
June 24, 2011
TCL Archive
J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.
July 18, 2008
TCL Archive
Sharfstein To Leave FDA
January 7, 2011
TCL Archive
Boyd’s Rebuttal to DePinho’s Letter to the AAUP
May 30, 2014